Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_assertion type Assertion NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_head.
- NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_assertion description "[Crizotinib was safe, well-tolerated, and effective in Chinese patients with pre-treated ALK-rearranged NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_provenance.
- NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_assertion evidence source_evidence_literature NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_provenance.
- NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_assertion SIO_000772 25501361 NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_provenance.
- NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_assertion wasDerivedFrom befree-2016 NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_provenance.
- NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_assertion wasGeneratedBy ECO_0000203 NP1247572.RAj_3rusqWdDLrQL6ockwP-_BedyFaA3rsrQeqBIhFa28130_provenance.